Q&A: Tariffs put MedTech innovation at risk and open door to counterfeits
Marcel Botha, CEO and founder of 10XBeta, a MedTech innovation firm and venture studio, joined MobiHealthNews to discuss the widespread and unintended consequences of tariffs imposed by the Trump Administration on the MedTech supply chain. Botha states that these tariffs will impact not only final medical products but also critical components and subassemblies, thereby hindering […]
Q&A: Tariffs put MedTech innovation at risk and open door to counterfeits Read More »